TreatOA4life (Treat OsteoArthritis4life) – a sustainable lifestyle treatment to improve outcomes in knee osteoarthritis
TreatOA4life (Treat OsteoArthritis4life) — 一种可持续的生活方式治疗,可改善膝骨关节炎的治疗效果
基本信息
- 批准号:nhmrc : 1150102
- 负责人:
- 金额:$ 12.07万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:Translating Research into Practice Fellowships
- 财政年份:2018
- 资助国家:澳大利亚
- 起止时间:2018-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Osteoarthritis (OA), the most common cause of arthritis, was estimated to cost $3.75 billion AUD in 2012. It has no cure or effective treatment and its cost is escalating with the obesity epidemic. Education, weight management and exercise reduce pain and slow the disease process, especially used early in disease. TreatOA4life will provide this treatment in a simple easy to access form in primary care, designed to improve OA outcomes in a self-sustaining fashion from initial diagnosis.
骨关节炎(OA)是导致关节炎的最常见原因,据估计,2012年的成本为37.5亿澳元。它没有治愈或有效的治疗方法,而且随着肥胖症的流行,它的成本正在上升。教育、体重管理和锻炼可以减轻疼痛,减缓疾病进程,尤其是在疾病的早期使用。TreatOA4life将在初级保健中以一种简单易用的形式提供这种治疗,旨在从最初的诊断开始以一种自我维持的方式改善OA结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A/Pr Anita Wluka其他文献
A/Pr Anita Wluka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A/Pr Anita Wluka', 18)}}的其他基金
TreatOA4life (Treat OsteoArthritis4life) – a sustainable lifestyle treatment to improve outcomes in knee osteoarthritis
TreatOA4life (Treat OsteoArthritis4life) — 一种可持续的生活方式治疗,可改善膝骨关节炎的治疗效果
- 批准号:
nhmrc : GNT1150102 - 财政年份:2018
- 资助金额:
$ 12.07万 - 项目类别:
Translating Research into Practice Fellowships
A randomised trial of krill oil for osteoarthritis of the knee
磷虾油治疗膝骨关节炎的随机试验
- 批准号:
nhmrc : 1102732 - 财政年份:2016
- 资助金额:
$ 12.07万 - 项目类别:
Project Grants
A randomised trial of krill oil for osteoarthritis of the knee
磷虾油治疗膝骨关节炎的随机试验
- 批准号:
nhmrc : GNT1102732 - 财政年份:2016
- 资助金额:
$ 12.07万 - 项目类别:
Project Grants
Is antibiotic treatment effective in the management of chronic low back pain in those with disc herniation? A double-blind, randomised, placebo-controlled trial with an economic evaluation.
抗生素治疗对治疗椎间盘突出症患者的慢性腰痛有效吗?
- 批准号:
nhmrc : GNT1080774 - 财政年份:2015
- 资助金额:
$ 12.07万 - 项目类别:
Project Grants
Does low dose amitriptyline reduce pain in knee osteoarthritis? A double blind, randomised, pragmatic, placebo controlled clinical trial of amitriptyline in addition to usual care
小剂量阿米替林可以减轻膝骨关节炎的疼痛吗?
- 批准号:
nhmrc : 1083664 - 财政年份:2015
- 资助金额:
$ 12.07万 - 项目类别:
Project Grants
Is antibiotic treatment effective in the management of chronic low back pain in those with disc herniation? A double-blind, randomised, placebo-controlled trial with an economic evaluation.
抗生素治疗对治疗椎间盘突出症患者的慢性腰痛有效吗?
- 批准号:
nhmrc : 1080774 - 财政年份:2015
- 资助金额:
$ 12.07万 - 项目类别:
Project Grants
Does low dose amitriptyline reduce pain in knee osteoarthritis? A double blind, randomised, pragmatic, placebo controlled clinical trial of amitriptyline in addition to usual care
小剂量阿米替林可以减轻膝骨关节炎的疼痛吗?
- 批准号:
nhmrc : GNT1083664 - 财政年份:2015
- 资助金额:
$ 12.07万 - 项目类别:
Project Grants
New approaches to the prevention and treatment of Musculoskeletal Disease
预防和治疗肌肉骨骼疾病的新方法
- 批准号:
nhmrc : 1063574 - 财政年份:2014
- 资助金额:
$ 12.07万 - 项目类别:
Career Development Fellowships
New approaches to the prevention and treatment of Musculoskeletal Disease
预防和治疗肌肉骨骼疾病的新方法
- 批准号:
nhmrc : GNT1063574 - 财政年份:2014
- 资助金额:
$ 12.07万 - 项目类别:
Career Development Fellowships
Targeting bone marrow lesions to find interventions in the progression of osteoarthritis
针对骨髓病变寻找骨关节炎进展的干预措施
- 批准号:
nhmrc : 1042482 - 财政年份:2013
- 资助金额:
$ 12.07万 - 项目类别:
Project Grants
相似海外基金
SBIR Phase I: Development of wearable medical device to detect and treat opioid overdose.
SBIR 第一阶段:开发可穿戴医疗设备来检测和治疗阿片类药物过量。
- 批准号:
2335577 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Standard Grant
SBIR Phase I: Novel Self-Closing, Transcatheter, Edge-to-Edge Repair Device to Percutaneously Treat Tricuspid Valve Regurgitation Using Jugular or Femoral Vein Access
SBIR 第一阶段:新型自闭合、经导管、边对边修复装置,利用颈静脉或股静脉通路经皮治疗三尖瓣反流
- 批准号:
2322197 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Standard Grant
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Collaborative R&D
Targeting soluble guanylate cyclase as a novel strategy to treat and prevent cardiac arrhythmias: efficacy and mechanisms
靶向可溶性鸟苷酸环化酶作为治疗和预防心律失常的新策略:功效和机制
- 批准号:
MR/Y003594/1 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Research Grant
Targeting axonal transport regulation by neurotrophic factors to treat peripheral nerve degeneration
通过神经营养因子调节轴突运输来治疗周围神经变性
- 批准号:
MR/Y010949/1 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Fellowship
Corneal epithelial cell bandage to treat persistent epithelial defect
角膜上皮细胞绷带治疗持续性上皮缺损
- 批准号:
MR/Y019385/1 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Research Grant
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
- 批准号:
10109165 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Launchpad
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Launchpad
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
- 批准号:
MR/Y019458/1 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Research Grant
In-Vitro evaluation of the effectiveness of a novel Dual Drug Coated Balloon catheter to treat Vascular and cardiovascular diseases
新型双药物涂层球囊导管治疗血管和心血管疾病有效性的体外评估
- 批准号:
10109618 - 财政年份:2024
- 资助金额:
$ 12.07万 - 项目类别:
Launchpad